Return to normal: COVID-19 vaccination under mitigation measures
View ORCID ProfileValentina Marziano, View ORCID ProfileGiorgio Guzzetta, View ORCID ProfileAlessia Mammone, View ORCID ProfileFlavia Riccardo, Piero Poletti, Filippo Trentini, Mattia Manica, Andrea Siddu, Paola Stefanelli, Patrizio Pezzotti, Marco Ajelli, Silvio Brusaferro, Giovanni Rezza, Stefano Merler
doi: https://doi.org/10.1101/2021.03.19.21253893
Valentina Marziano
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
Giorgio Guzzetta
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
Alessia Mammone
3Ministry of Health, Rome, Italy
Flavia Riccardo
4Istituto Superiore di Sanità, Rome, Italy
Piero Poletti
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
Filippo Trentini
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
Mattia Manica
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
Andrea Siddu
3Ministry of Health, Rome, Italy
Paola Stefanelli
4Istituto Superiore di Sanità, Rome, Italy
Patrizio Pezzotti
4Istituto Superiore di Sanità, Rome, Italy
Marco Ajelli
5Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, United States
6Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, United States
Silvio Brusaferro
4Istituto Superiore di Sanità, Rome, Italy
Giovanni Rezza
3Ministry of Health, Rome, Italy
Stefano Merler
1Center for Health Emergencies, Bruno Kessler Foundation, Trento, Italy
2Epilab-JRU, FEM-FBK Joint Research Unit, Trento, Italy
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Appendix[supplements/253893_file07.pdf]
Posted March 20, 2021.
Return to normal: COVID-19 vaccination under mitigation measures
Valentina Marziano, Giorgio Guzzetta, Alessia Mammone, Flavia Riccardo, Piero Poletti, Filippo Trentini, Mattia Manica, Andrea Siddu, Paola Stefanelli, Patrizio Pezzotti, Marco Ajelli, Silvio Brusaferro, Giovanni Rezza, Stefano Merler
medRxiv 2021.03.19.21253893; doi: https://doi.org/10.1101/2021.03.19.21253893
Return to normal: COVID-19 vaccination under mitigation measures
Valentina Marziano, Giorgio Guzzetta, Alessia Mammone, Flavia Riccardo, Piero Poletti, Filippo Trentini, Mattia Manica, Andrea Siddu, Paola Stefanelli, Patrizio Pezzotti, Marco Ajelli, Silvio Brusaferro, Giovanni Rezza, Stefano Merler
medRxiv 2021.03.19.21253893; doi: https://doi.org/10.1101/2021.03.19.21253893
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)